Advaxis Inc. (ADXS.OB)

Advaxis, Inc., a development stage biotechnology company, engages in the research and development of cancer-fighting techniques primarily in the United States. The company develops therapeutic cancer vaccines targeting cervical, head and neck, breast, prostate, and other cancers. Its products in development stage include ADXS11-001, a Phase I/II trial product for cervical intraepithelial neoplasia, cervical cancer, and head and neck cancer; ADXS31-142, a Phase I trial product for prostate cancer; and ADXS31-164, a Phase I trial product for breast cancer. The company has strategic collaboration agreement with Cobra Biomanufacturing PLC to manufacture cervical cancer vaccine. Advaxis, Inc. was founded in 2002 and is based in North Brunswick, New Jersey.